Bank of America’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-26,509
| Closed | -$23K | – | 7634 |
|
|
2019
Q4 | $23K | Sell |
26,509
-116
| -0.4% | -$89 | ﹤0.01% | 6480 |
|
|
2019
Q3 | $14K | Buy |
26,625
+6,333
| +31% | +$3.41K | ﹤0.01% | 6664 |
|
|
2019
Q2 | $10K | Sell |
20,292
-70
| -0.3% | -$35 | ﹤0.01% | 6741 |
|
|
2019
Q1 | $10K | Buy |
20,362
+7,474
| +58% | +$3.49K | ﹤0.01% | 6674 |
|
|
2018
Q4 | $6K | Sell |
12,888
-1,595
| -11% | -$792 | ﹤0.01% | 6751 |
|
|
2018
Q3 | $7K | Sell |
14,483
-1,997
| -12% | -$1.07K | ﹤0.01% | 6774 |
|
|
2018
Q2 | $8K | Sell |
16,480
-529
| -3% | -$246 | ﹤0.01% | 6730 |
|
|
2018
Q1 | $7K | Sell |
17,009
-178
| -1% | -$72 | ﹤0.01% | 6722 |
|
|
2017
Q4 | $6K | Sell |
17,187
-387
| -2% | -$147 | ﹤0.01% | 6723 |
|
|
2017
Q3 | $6K | Sell |
17,574
-99,782
| -85% | -$36.9K | ﹤0.01% | 6712 |
|
|
2017
Q2 | $45K | Sell |
117,356
-1,400
| -1% | -$571 | ﹤0.01% | 5918 |
|
|
2017
Q1 | $53K | Sell |
118,756
-6,764
| -5% | -$2.97K | ﹤0.01% | 5912 |
|
|
2016
Q4 | $47K | Buy |
125,520
+130
| +0.1% | +$44 | ﹤0.01% | 5967 |
|
|
2016
Q3 | $33K | Sell |
125,390
-2,595
| -2% | -$657 | ﹤0.01% | 5915 |
|
|
2016
Q2 | $30K | Sell |
127,985
-359,278
| -74% | -$61.8K | ﹤0.01% | 6087 |
|
|
2016
Q1 | $55K | Buy |
487,263
+3,709
| +0.8% | +$402 | ﹤0.01% | 5753 |
|
|
2015
Q4 | $55K | Sell |
483,554
-3,065
| -0.6% | -$433 | ﹤0.01% | 6005 |
|
|
2015
Q3 | $92K | Buy |
486,619
+5,397
| +1% | +$1.84K | ﹤0.01% | 5698 |
|
|
2015
Q2 | $336K | Sell |
481,222
-1,939
| -0.4% | -$1.34K | ﹤0.01% | 4972 |
|
|
2015
Q1 | $327K | Sell |
483,161
-1,475
| -0.3% | -$1.03K | ﹤0.01% | 4609 |
|
|
2014
Q4 | $383K | Buy |
484,636
+6,438
| +1% | +$4.4K | ﹤0.01% | 4854 |
|
|
2014
Q3 | $222K | Buy |
478,198
+538
| +0.1% | +$261 | ﹤0.01% | 5301 |
|
|
2014
Q2 | $239K | Sell |
477,660
-1,926
| -0.4% | -$931 | ﹤0.01% | 5391 |
|
|
2014
Q1 | $148K | Buy |
479,586
+96,917
| +25% | +$36K | ﹤0.01% | 5681 |
|
|
2013
Q4 | $130K | Sell |
382,669
-857,024
| -69% | -$1.04M | ﹤0.01% | 5937 |
|
|
2013
Q3 | $2.5M | Buy |
1,239,693
+349,529
| +39% | +$666K | ﹤0.01% | 3039 |
|
|
2013
Q2 | $1.69M | Buy |
+890,164
| New | +$1.56M | ﹤0.01% | 3420 |
|
Bank of America's GCVRZ Position: Q1 2020 in Review
Bank of America sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 26,509 shares — an estimated $23K sold.
Bank of America first reported a position in GCVRZ in Q2 2013 and held it in 27 quarters. The position peaked at $2.5M in Q3 2013. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- Bank of America reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- Bank of America sold 26,509 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $23K.
- Bank of America first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 27 quarters.
- Bank of America's Sanofi Contingent Value Rights position peaked at $2.5M in Q3 2013.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on Bank of America's 13F filing for Q1 2020, filed 15 May 2020.